{"id":1064661,"date":"2021-02-08T08:00:36","date_gmt":"2021-02-08T07:00:36","guid":{"rendered":"https:\/\/frezzapartners.com\/?p=1064661"},"modified":"2021-02-05T16:53:04","modified_gmt":"2021-02-05T15:53:04","slug":"jazz-pharmaceuticals-acquista-gw-pharma","status":"publish","type":"post","link":"https:\/\/frezzapartners.com\/en\/jazz-pharmaceuticals-acquista-gw-pharma\/","title":{"rendered":"Jazz Pharmaceuticals acquista GW Pharma"},"content":{"rendered":"<p>photo by pexels<\/p>\n<p>&nbsp;<\/p>\n<p>Jazz Pharmaceuticals ha acquisito GW Pharmaceuticals, produttore britannico attivo nel campo della ricerca sui cannabinoidi, per 7,2 miliardi in contanti e azioni.<\/p>\n<p>GW \u00e8 un&#8217;azienda operante nella scoperta, sviluppo, produzione e commercializzazione di nuove terapie approvate dalla sua piattaforma proprietaria di prodotti cannabinoidi per affrontare una vasta gamma di malattie.<\/p>\n<p>Il prodotto di punta dell&#8217;azienda, Epidiolex (cannabidiolo) soluzione orale, \u00e8 approvato nei pazienti da un anno in su per il trattamento delle crisi associate alla sindrome di Lennox-Gastaut (LGS), alla sindrome di Dravet e al complesso della sclerosi tuberosa (TSC), tutte malattie rare caratterizzate da una grave epilessia precoce. Epidiolex \u00e8 stato il primo farmaco a base di cannabinoidi di origine vegetale mai approvato dalla Food and Drug Administration (FDA) degli Stati Uniti.<\/p>\n<p><em>&#8220;Jazz \u00e8 orgogliosa della nostra posizione di leadership nelle medicine per il sonno e del nostro business oncologico in rapida crescita. Siamo entusiasti di aggiungere la piattaforma di cannabinoidi, la pipeline e i prodotti innovativi di GW, che rafforzeranno e amplieranno il nostro portafoglio di neuroscienze, diversificando ulteriormente le nostre entrate e creando opportunit\u00e0 di valore sostenibile a lungo termine&#8221;<\/em>, ha commentato Bruce Cozadd, presidente e CEO di Jazz Pharmaceuticals.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>photo by pexels &nbsp; Jazz Pharmaceuticals ha acquisito GW Pharmaceuticals, produttore britannico attivo nel campo della ricerca sui cannabinoidi, per 7,2 miliardi in contanti e azioni. GW \u00e8 un&#8217;azienda operante nella scoperta, sviluppo, produzione e commercializzazione di nuove terapie approvate dalla sua piattaforma proprietaria di prodotti cannabinoidi per affrontare una vasta gamma di malattie. Il prodotto di punta dell&#8217;azienda, Epidiolex (cannabidiolo) soluzione orale, \u00e8 approvato nei pazienti da un anno in su per il trattamento delle crisi associate alla sindrome&#8230;<\/p>\n","protected":false},"author":297440,"featured_media":1064665,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[141],"tags":[2852,3063,3062],"class_list":["post-1064661","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-acquisizione","tag-gw","tag-jazz"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Jazz Pharmaceuticals acquista GW Pharma - Frezza Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/frezzapartners.com\/jazz-pharmaceuticals-acquista-gw-pharma\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Jazz Pharmaceuticals acquista GW Pharma - Frezza Partners\" \/>\n<meta property=\"og:description\" content=\"photo by pexels &nbsp; Jazz Pharmaceuticals ha acquisito GW Pharmaceuticals, produttore britannico attivo nel campo della ricerca sui cannabinoidi, per 7,2 miliardi in contanti e azioni. GW \u00e8 un&#8217;azienda operante nella scoperta, sviluppo, produzione e commercializzazione di nuove terapie approvate dalla sua piattaforma proprietaria di prodotti cannabinoidi per affrontare una vasta gamma di malattie. Il prodotto di punta dell&#8217;azienda, Epidiolex (cannabidiolo) soluzione orale, \u00e8 approvato nei pazienti da un anno in su per il trattamento delle crisi associate alla sindrome...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/frezzapartners.com\/jazz-pharmaceuticals-acquista-gw-pharma\/\" \/>\n<meta property=\"og:site_name\" content=\"Frezza Partners\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-08T07:00:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/02\/pexels-pixabay-261621-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1920\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Frezza Partners\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Frezza Partners\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/jazz-pharmaceuticals-acquista-gw-pharma\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/jazz-pharmaceuticals-acquista-gw-pharma\\\/\"},\"author\":{\"name\":\"Frezza Partners\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\"},\"headline\":\"Jazz Pharmaceuticals acquista GW Pharma\",\"datePublished\":\"2021-02-08T07:00:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/jazz-pharmaceuticals-acquista-gw-pharma\\\/\"},\"wordCount\":199,\"image\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/jazz-pharmaceuticals-acquista-gw-pharma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/pexels-pixabay-261621-scaled.jpg\",\"keywords\":[\"acquisizione\",\"gw\",\"jazz\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/jazz-pharmaceuticals-acquista-gw-pharma\\\/\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/jazz-pharmaceuticals-acquista-gw-pharma\\\/\",\"name\":\"Jazz Pharmaceuticals acquista GW Pharma - Frezza Partners\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/jazz-pharmaceuticals-acquista-gw-pharma\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/jazz-pharmaceuticals-acquista-gw-pharma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/pexels-pixabay-261621-scaled.jpg\",\"datePublished\":\"2021-02-08T07:00:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/jazz-pharmaceuticals-acquista-gw-pharma\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/frezzapartners.com\\\/jazz-pharmaceuticals-acquista-gw-pharma\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/jazz-pharmaceuticals-acquista-gw-pharma\\\/#primaryimage\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/pexels-pixabay-261621-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/pexels-pixabay-261621-scaled.jpg\",\"width\":2560,\"height\":1920},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/jazz-pharmaceuticals-acquista-gw-pharma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/frezzapartners.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Jazz Pharmaceuticals acquista GW Pharma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#website\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/\",\"name\":\"Frezza Partners\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/frezzapartners.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\",\"name\":\"Frezza Partners\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/en\\\/author\\\/fr3zz4partn3rs\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Jazz Pharmaceuticals acquista GW Pharma - Frezza Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/frezzapartners.com\/jazz-pharmaceuticals-acquista-gw-pharma\/","og_locale":"en_US","og_type":"article","og_title":"Jazz Pharmaceuticals acquista GW Pharma - Frezza Partners","og_description":"photo by pexels &nbsp; Jazz Pharmaceuticals ha acquisito GW Pharmaceuticals, produttore britannico attivo nel campo della ricerca sui cannabinoidi, per 7,2 miliardi in contanti e azioni. GW \u00e8 un&#8217;azienda operante nella scoperta, sviluppo, produzione e commercializzazione di nuove terapie approvate dalla sua piattaforma proprietaria di prodotti cannabinoidi per affrontare una vasta gamma di malattie. Il prodotto di punta dell&#8217;azienda, Epidiolex (cannabidiolo) soluzione orale, \u00e8 approvato nei pazienti da un anno in su per il trattamento delle crisi associate alla sindrome...","og_url":"https:\/\/frezzapartners.com\/jazz-pharmaceuticals-acquista-gw-pharma\/","og_site_name":"Frezza Partners","article_published_time":"2021-02-08T07:00:36+00:00","og_image":[{"width":2560,"height":1920,"url":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/02\/pexels-pixabay-261621-scaled.jpg","type":"image\/jpeg"}],"author":"Frezza Partners","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Frezza Partners","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/frezzapartners.com\/jazz-pharmaceuticals-acquista-gw-pharma\/#article","isPartOf":{"@id":"https:\/\/frezzapartners.com\/jazz-pharmaceuticals-acquista-gw-pharma\/"},"author":{"name":"Frezza Partners","@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0"},"headline":"Jazz Pharmaceuticals acquista GW Pharma","datePublished":"2021-02-08T07:00:36+00:00","mainEntityOfPage":{"@id":"https:\/\/frezzapartners.com\/jazz-pharmaceuticals-acquista-gw-pharma\/"},"wordCount":199,"image":{"@id":"https:\/\/frezzapartners.com\/jazz-pharmaceuticals-acquista-gw-pharma\/#primaryimage"},"thumbnailUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/02\/pexels-pixabay-261621-scaled.jpg","keywords":["acquisizione","gw","jazz"],"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/frezzapartners.com\/jazz-pharmaceuticals-acquista-gw-pharma\/","url":"https:\/\/frezzapartners.com\/jazz-pharmaceuticals-acquista-gw-pharma\/","name":"Jazz Pharmaceuticals acquista GW Pharma - Frezza Partners","isPartOf":{"@id":"https:\/\/frezzapartners.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/frezzapartners.com\/jazz-pharmaceuticals-acquista-gw-pharma\/#primaryimage"},"image":{"@id":"https:\/\/frezzapartners.com\/jazz-pharmaceuticals-acquista-gw-pharma\/#primaryimage"},"thumbnailUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/02\/pexels-pixabay-261621-scaled.jpg","datePublished":"2021-02-08T07:00:36+00:00","author":{"@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0"},"breadcrumb":{"@id":"https:\/\/frezzapartners.com\/jazz-pharmaceuticals-acquista-gw-pharma\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/frezzapartners.com\/jazz-pharmaceuticals-acquista-gw-pharma\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/frezzapartners.com\/jazz-pharmaceuticals-acquista-gw-pharma\/#primaryimage","url":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/02\/pexels-pixabay-261621-scaled.jpg","contentUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/02\/pexels-pixabay-261621-scaled.jpg","width":2560,"height":1920},{"@type":"BreadcrumbList","@id":"https:\/\/frezzapartners.com\/jazz-pharmaceuticals-acquista-gw-pharma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/frezzapartners.com\/"},{"@type":"ListItem","position":2,"name":"Jazz Pharmaceuticals acquista GW Pharma"}]},{"@type":"WebSite","@id":"https:\/\/frezzapartners.com\/#website","url":"https:\/\/frezzapartners.com\/","name":"Frezza Partners","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/frezzapartners.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0","name":"Frezza Partners","url":"https:\/\/frezzapartners.com\/en\/author\/fr3zz4partn3rs\/"}]}},"_links":{"self":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts\/1064661","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/users\/297440"}],"replies":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/comments?post=1064661"}],"version-history":[{"count":0,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts\/1064661\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/media\/1064665"}],"wp:attachment":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/media?parent=1064661"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/categories?post=1064661"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/tags?post=1064661"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}